[1]顾亮亮 王建锋 乔鑫 张保朝 傅国惠.急性缺血性脑卒中患者静脉溶栓前后SCUBE1水平的变化及其与预后不良的相关性分析[J].卒中与神经疾病杂志,2023,30(03):265-268,288.[doi:10.3969/j.issn.1007-0478.2023.03.006]
　Gu Liangliang*,Wang Jianfeng,Qiao Xin*,et al.Changes of SCUBE1 levels after thrombolytic therapy in patients with acute ischemic stroke and its correlation with prognosis[J].Stroke and Nervous Diseases,2023,30(03):265-268,288.[doi:10.3969/j.issn.1007-0478.2023.03.006]
点击复制

急性缺血性脑卒中患者静脉溶栓前后SCUBE1水平的变化及其与预后不良的相关性分析()
分享到：

《卒中与神经疾病》杂志[ISSN:1007-0478/CN:42-1402/R]

卷:
第30卷
期数:
2023年03期
页码:
265-268,288
栏目:
论著
出版日期:
2023-06-20

文章信息/Info

Title:
Changes of SCUBE1 levels after thrombolytic therapy in patients with acute ischemic stroke and its correlation with prognosis
文章编号:
1007-0478(2023)03-0265-05
作者:
顾亮亮 王建锋 乔鑫 张保朝 傅国惠
473000 河南省南阳市中心医院神经内科[顾亮亮 乔鑫 张保朝 傅国惠(通信作者)],普外科(王建锋)
Author(s):
Gu Liangliang*;  Wang Jianfeng;  Qiao Xin*;  et al.
*Department of Neurology, Nanyang Central Hospital, Nanyang, Henan 473000
关键词:
急性缺血性脑卒中; 静脉溶栓; 血浆信号肽; Cub-Egf结构域蛋白-1
Keywords:
Acute ischemic stroke; Intravenous thrombolysis; Plasma signal peptide; Cub-Egf structural domain protein 1
分类号:
R743.3
DOI:
10.3969/j.issn.1007-0478.2023.03.006
文献标志码:
A
摘要:
目的 探讨急性缺血性脑卒中患者静脉溶栓前后血浆信号肽Cub-Egf结构域蛋白1(Plasma signal peptide Cub Egf domain protein 1,SCUBE1)水平变化及血浆SCUBE1水平对患者预后不良的预测价值。方法 纳入2020年1月-2022年1月本院收治的116例急性缺血性脑卒中患者作为研究对象,另选取同期体检健康者120例作为对照组,收集患者临床资料,测定研究对象血浆SCUBE1水平,比较患者与对照组以及患者治疗不同时间点(治疗前、治疗2、12、24 h、3 d后)血浆SCUBE1水平,比较不同预后情况患者临床资料以及血浆SCUBE1水平差异,用受试者工作特征(Receiver operating characteristic,ROC)曲线分析血浆SCUBE1水平对急性缺血性脑卒中患者静脉溶栓后预后不良的预测价值。结果 与对照组比较,急性脑卒中组患者血浆SCUBE1水平升高(P<0.05); 与治疗前比较,治疗2、12、24 h后血浆SCUBE1水平升高(P<0.05),治疗3 d后血浆SCUBE1水平降低(P<0.05); 与治疗12 h后比较,治疗24 h、3 d后血浆SCUBE1水平降低(P<0.05); 预后不良组患者高血压病、高脂血症、糖尿病、心房颤动比例、基线美国国立卫生院卒中量表(National institutes of health stroke scale,NIHSS)评分、血浆SCUBE1水平高于预后良好组(P<0.05); 基线NIHSS评分、血浆SCUBE1水平是患者预后不良的独立危险因素(P<0.05); 血浆SCUBE1水平预测急性脑卒中患者静脉溶栓后预后不良的曲线下面积(Area under curve,AUC)为0.860(敏感度为73.0%,特异性为88.6%)。结论 急性缺血性脑卒中患者血浆SCUBE1水平升高,经静脉溶栓后水平降低,患者治疗前血浆SCUBE1水平有望成为患者短期预后不良的预测因子。
Abstract:
ObjectiveTo investigate the changes of plasma signal peptide Cub-Egf structural domain protein 1(SCUBE1)levels after intravenous thrombolysis in acute ischemic stroke patients and the predictive value of plasma SCUBE1 levels on patients' prognosis.Methods 116 acute ischemic stroke patients admitted to our hospital from January 2020 to January 2022 were enrolled as study subjects, and 120 healthy persons were selected as the control group during the same period. The clinical data of patients were collected, and the levels of plasma SCUBE1 in the subjects were measured. The level of plasma SCUBE1 was compared between the patients and the healthy controls and among patients at different time points after treatment(0 h, 2 h, 12 h, 24 h, and 3 d after treatment). The clinical data and plasma SCUBE1 levels of patients with different prognoses were compared. The receiver operating characteristic(ROC)curve was used to analyze the predictive value of plasma SCUBE1 levels for poor prognosis after intravenous thrombolysis in patients with acute ischemic stroke.Results Compared with the control group, plasma SCUBE1 levels were increased in the acute stroke group(P<0.05). Compared with pre-treatment, plasma SCUBE1 levels were increased after 2, 12, and 24 h of treatment(P<0.05)and decreased after 3 d of treatment(P<0.05). Compared with after 12 h of treatment, plasma SCUBE1 levels were decreased after 24 h and 3 d of treatment(P<0.05)and lower in the poor-prognosis group than in the good-prognosis group(P<0.05). The proportion of patients with hypertension, hyperlipidemia, diabetes mellitus, atrial fibrillation, baseline National Institutes of Health Stroke Scale(NIHSS)scores, and plasma SCUBE1 levels were higher in the poor-prognosis group(P<0.05). The NIHSS score and plasma SCUBE1 level were independent risk factors for poor prognosis(P<0.05). The area under the curve(AUC)of plasma SCUBE1 level to predict poor prognosis after intravenous thrombolysis in acute stroke patients was 0.860(sensitivity 73.0%, specificity 88.6%).Conclusion Plasma SCUBE1 levels are elevated in patients with acute ischemic stroke and decreased after intravenous thrombolysis. Thus, plasma SCUBE1 levels are expected to be a predictor of poor short-term prognosis in patients.

参考文献/References:

[1] Ioannidis GS, Nikiforaki K, Trivizakis E, et al. Cerebral CT perfusion in acute stroke:the effect of lowering the tube load and sampling rate on the reproducibility of parametric Maps[J]. Diagnostics(Basel), 2021, 11(6): 1121.
[2] 朱淼,徐树军,罗璇,等.急性脑卒中发病后认知功能改变的患者MRS与MoCA得分相关性分析[J].医学综述,2020,26(1):164-168.
[3] 戴敏慧,陈响亮,张羽乔,等.入院至静脉溶栓时间与轻型缺血性卒中短期转归的相关性[J].国际脑血管病杂志,2021,29(10):738-743.
[4] Jackson D, Earnshaw SR, Farkouh R, et al. Cost-effectiveness of CT perfusion for selecting patients for intravenous thrombolysis:a US hospital perspective[J]. AJNR Am J Neuroradiol, 2010, 31(9): 1669-1674.
[5] 赵晖,王玉,吕虹,等.缺血性脑卒中溶栓患者出凝血变化规律的探讨[J].国际检验医学杂志,2020,41(9):1069-1073.
[6] 李俊,李国庆.新型分泌型蛋白SCUBE1在急性冠脉综合征中促进无复流的研究进展[J].新疆医学,2018,48(1):91-93.
[7] 崔波,靳斐,王莉格.IMA与SCUBE1联合检测在急性肺栓塞诊断中的价值[J].安徽医学,2018,39(6):669-672.
[8] 中华医学会神经病学分会.中华医学会神经病学分会脑血管病学组.中国急性缺血性脑卒中诊治指南2018[J].中华神经科杂志,2018,51(9):666-682.
[9] Muchada M, Rubiera M, Rodriguez-Luna D, et al. Baseline National institutes of health stroke scale-adjusted time window for intravenous tissue-type plasminogen activator in acute ischemic stroke[J]. Stroke, 2014, 45(4): 1059-1063.
[10] 刘建民.多模式血管再通在急性缺血性脑卒中治疗中的应用[J].心脑血管病防治,2020,20(1):48-49.
[11] Koh PX, Ti J, Saffari SE, et al. Hemisensory syndrome: hyperacute symptom onset and age differentiates ischemic stroke from other aetiologies[J]. BMC Neurol, 2021, 21(1): 179.
[12] 李宏建.阿替普酶静脉溶栓对抽吸取栓和支架取栓疗效的不同影响[J].国际脑血管病杂志,2022,30(1):65-65.
[13] Cheng TF, Zhao J, Wu QL, et al. Compound Dan Zhi tablet attenuates experimental ischemic stroke via inhibiting platelet activation and thrombus formation[J]. Phytomedicine, 2020, 79: 153330.
[14] Pan H, Fu M, Ge W, et al. The effects of changes in platelet-to-neutrophil ratios 24 hours after intravenous thrombolysis on prognosis in acute ischemic stroke patients[J]. Clin Neurol Neurosurg, 2020, 190: 105739.
[15] Dai DF, Thajeb P, Tu CF, et al. Plasma concentration of SCUBE1, a novel platelet protein,is elevated in patients with acute coronary syndrome and ischemic stroke[J]. J Am Coll Cardiol, 2008, 51(22): 2173-2180.
[16] Lopez LR, Guyer KE, Torre IL, et al. Platelet thromboxane(11-dehydro-Thromboxane B2)and aspirin response in patients with diabetes and coronary artery disease[J]. World J Diabetes, 2014, 5(2): 115-127.
[17] 师艳莉,田洪森,孙江江,等.急性ST段抬高型心肌梗死患者血清HPSE和SCUBE1水平与血栓负荷的关系研究[J].临床急诊杂志,2021,22(12):851-855.

相似文献/References:

[1]白文婷,杨丽荣,吕利英,等.多个危险因素聚集与急性缺血性脑卒中患者出院结局不良的关系[J].卒中与神经疾病杂志,2015,22(02):71.
[2]陈翠荣,赵振国,周媛,等.轻中度急性脑梗死MRI指导下超时间窗静脉溶栓治疗的研究[J].卒中与神经疾病杂志,2014,21(06):330.
[3]但毕堂,彭小祥,陈小奇,等.急性缺血性脑卒中时间窗内的动静脉溶栓分层治疗的对比研究[J].卒中与神经疾病杂志,2014,21(06):334.
[4]张蓉,吴军.脑梗死溶栓与抗栓治疗进展[J].卒中与神经疾病杂志,2014,21(06):399.
[5]宗彦武,蔡柳燕,张岩.神经介入联合阿加曲班对急性缺血性脑卒中患者血清FIB,D-D表达水平的影响[J].卒中与神经疾病杂志,2022,29(04):365.[doi:10.3969/j.issn.1007-0478.2022.04.012]
[6]李海峰,李振华,刘丽娟.急性缺血性脑卒中患者血清Survivin,Hepc25水平变化及其临床意义[J].卒中与神经疾病杂志,2022,29(05):432.[doi:10.3969/j.issn.1007-0478.2022.05.007]
　Li Haifeng*,Li Zhenhua,Liu Lijuan*..Changes in serum Survivin and Hepc25 levels in patients with acute ischemic stroke and their clinical significance[J].Stroke and Nervous Diseases,2022,29(03):432.[doi:10.3969/j.issn.1007-0478.2022.05.007]
[7]秦雅鑫 任占云 李杰 许冬华 叶沈早 陈蒋楠.Willis环完整性和脑白质变化对急性缺血性脑卒中患者神经功能缺损及预后的影响[J].卒中与神经疾病杂志,2023,30(03):259.[doi:10.3969/j.issn.1007-0478.2023.03.005]
　Qin Yaxin,Ren Zhanyun,Li Jie,et al.Effects of Willis ring integrity and white matter changes on neurological deficit and prognosis in patients with acute ischemic stroke[J].Stroke and Nervous Diseases,2023,30(03):259.[doi:10.3969/j.issn.1007-0478.2023.03.005]
[8]孙光文 徐仕皓 王媛媛 毛瑞 杨文琼.PTX3联合LP-PLA2水平与急性缺血性脑卒中合并颈动脉狭窄的关系[J].卒中与神经疾病杂志,2023,30(03):273.[doi:10.3969/j.issn.1007-0478.2023.03.008]
　Sun Guangwen*,Xu Shihao,Wang Ruanruan,et al.Correlation analysis of PTX3 combined with LP-PLA2 in carotid stenosis in acute ischemic stroke[J].Stroke and Nervous Diseases,2023,30(03):273.[doi:10.3969/j.issn.1007-0478.2023.03.008]
[9]龚汉贤,庄泽微,李述桃,等.球囊导引导管在老年急性缺血性脑卒中患者取栓治疗中的作用[J].卒中与神经疾病杂志,2024,31(01):73.[doi:10.3969/j.issn.1007-0478.2024.01.012]

备注/Memo

备注/Memo:
基金项目:河南省医学科技攻关计划项目(192102310349)
更新日期/Last Update: 2023-06-20